RecruitingNot applicableNCT07485517

Deep Versus Moderate Neuromuscular Blocking

Studying Opsoclonus-myoclonus syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Menoufia University
Principal Investigator
Rabab M Habeeb
Faculty of Medicine Menoufia University
Intervention
Moderate Neuromuscular Blockade(drug)
Enrollment
88 target
Eligibility
18-60 years · FEMALE
Timeline
20262026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07485517 on ClinicalTrials.gov

Other trials for Opsoclonus-myoclonus syndrome

Additional recruiting or active studies for the same condition.

See all trials for Opsoclonus-myoclonus syndrome

← Back to all trials